National HealthCare Corporation Announces 2024 Annual Meeting of Shareholders

Ticker: NHC · Form: DEF 14A · Filed: Apr 5, 2024 · CIK: 1047335

Sentiment: neutral

Topics: proxy statement, annual meeting, shareholder vote, corporate governance, National HealthCare Corp

TL;DR

<b>National HealthCare Corporation invites shareholders to its 2024 Annual Meeting on May 9, 2024, urging proxy voting.</b>

AI Summary

NATIONAL HEALTHCARE CORP (NHC) filed a Proxy Statement (DEF 14A) with the SEC on April 5, 2024. The 2024 Annual Meeting of Shareholders for National HealthCare Corporation (NHC) will be held on May 9, 2024, at 3:30 PM CDT. The meeting will take place on the 14th Floor of the City Center building at 100 E. Vine Street, Murfreesboro, Tennessee. Shareholders are urged to vote and submit their proxy in advance via telephone or online. The Notice of Meeting and Proxy Statement will detail business items and include a report on the company's performance. The 2023 Annual Report to Shareholders is enclosed but is not part of the proxy solicitation materials.

Why It Matters

For investors and stakeholders tracking NATIONAL HEALTHCARE CORP, this filing contains several important signals. This filing is a definitive proxy statement (DEF 14A) for the annual shareholder meeting, indicating formal communication regarding corporate governance and voting matters. The company is actively soliciting shareholder votes for the upcoming meeting, highlighting the importance of shareholder participation in corporate decisions.

Risk Assessment

Risk Level: — NATIONAL HEALTHCARE CORP shows moderate risk based on this filing. The filing is a routine proxy statement for an annual meeting, with no immediate financial or operational risks indicated.

Analyst Insight

Shareholders should review the proxy materials to understand the agenda items and cast their votes to influence corporate governance.

Key Numbers

Key Players & Entities

FAQ

When did NATIONAL HEALTHCARE CORP file this DEF 14A?

NATIONAL HEALTHCARE CORP filed this Proxy Statement (DEF 14A) with the SEC on April 5, 2024.

What is a DEF 14A filing?

A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by NATIONAL HEALTHCARE CORP (NHC).

Where can I read the original DEF 14A filing from NATIONAL HEALTHCARE CORP?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by NATIONAL HEALTHCARE CORP.

What are the key takeaways from NATIONAL HEALTHCARE CORP's DEF 14A?

NATIONAL HEALTHCARE CORP filed this DEF 14A on April 5, 2024. Key takeaways: The 2024 Annual Meeting of Shareholders for National HealthCare Corporation (NHC) will be held on May 9, 2024, at 3:30 PM CDT.. The meeting will take place on the 14th Floor of the City Center building at 100 E. Vine Street, Murfreesboro, Tennessee.. Shareholders are urged to vote and submit their proxy in advance via telephone or online..

Is NATIONAL HEALTHCARE CORP a risky investment based on this filing?

Based on this DEF 14A, NATIONAL HEALTHCARE CORP presents a moderate-risk profile. The filing is a routine proxy statement for an annual meeting, with no immediate financial or operational risks indicated.

What should investors do after reading NATIONAL HEALTHCARE CORP's DEF 14A?

Shareholders should review the proxy materials to understand the agenda items and cast their votes to influence corporate governance. The overall sentiment from this filing is neutral.

How does NATIONAL HEALTHCARE CORP compare to its industry peers?

National HealthCare Corporation operates within the skilled nursing care facilities industry, providing healthcare services.

Are there regulatory concerns for NATIONAL HEALTHCARE CORP?

This filing is a Schedule 14A (DEF 14A) under the Securities Exchange Act of 1934, used for proxy statements.

Industry Context

National HealthCare Corporation operates within the skilled nursing care facilities industry, providing healthcare services.

Regulatory Implications

This filing is a Schedule 14A (DEF 14A) under the Securities Exchange Act of 1934, used for proxy statements.

What Investors Should Do

  1. Review the proxy statement for details on agenda items and proposals.
  2. Cast your vote by telephone, online, or mail to ensure your voice is heard.
  3. Read the enclosed 2023 Annual Report for insights into the company's performance.

Key Dates

Year-Over-Year Comparison

This is a definitive proxy statement (DEF 14A) filed for the 2024 Annual Meeting of Shareholders, indicating a routine annual corporate event.

Filing Stats: 4,893 words · 20 min read · ~16 pages · Grade level 9.1 · Accepted 2024-04-05 16:30:59

Key Financial Figures

Filing Documents

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)). Definitive Proxy Statement. Definitive Additional Materials . Soliciting Material under 240.14a-12. National HealthCare Corporation (Name of Registrant as Specified in Its Charter) (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required . Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. April 5, 2024 Dear Fellow Shareholder: It is our pleasure to invite you to attend National HealthCare Corporation's 2024 Annual Meeting of Shareholders ("Meeting") on Thursday, May 9, 2024, at 3:30 PM CDT on the 14 th Floor of the City Center building located at 100 E. Vine Street, Murfreesboro, Tennessee 37130. Whether or not you plan to attend the Meeting, we urge you to vote and submit your proxy in advance of the Meeting by one of the methods described in the proxy materials for the Meeting. The Notice of Meeting and Proxy Statement in this mailing describe the business items we plan to address at the Meeting. We will also present a brief report on our business and respond to your questions. Our 2023 Annual Report to Shareholders, which is not a part of our proxy solicitations materials, is also enclosed. We encourage you to read our Annual Report. Your vote is very important. Please take the time to cast your vote regardless of the number of shares you own. You have the option to cast your proxy vote by telephone (1-800-690-6903) or online at www.proxyvote.com as provided by Broadridge Financial Solutions. These are quick, cost-effective and easy ways for you to submit your proxy. If you vote by telephone or via the internet, you do not need to return the enclosed proxy card by mail. If you prefer to vote by mail, please promptly sign, date and return the enclosed proxy card in the postage-paid envelope provided. We look forward to seeing you on Thursday, May 9, 2024. Best regards, Robert G. Adams Chairman of the Board Stephen F. Flatt Chief Executive Officer NHC 100 East Vine Street | Murfreesboro, Tennessee | 37130 NOTICE OF ANNUAL MEETING OF SHAREHOLDERS The 2024 Annual Meeting of the Shareholders of National HealthCare Corporation ("NHC") will be held on the 14 th Floor of the City Center located at 100 East Vine Street, Murfreesboro, TN 37130 on Thursday, May 9, 2024, at 3:30 PM CDT (the "Meeting"). A list of shareholders of record as of the record date is available for inspection by shareholders at the principal executive offices of the Company located at 100 East Vine Street, Murfreesboro, TN 37130, and will be available for inspection by shareholders at the Meeting. All requests to access the list prior to the Meeting should be directed to Josh A. McCreary, Senior Vice President and General Counsel, at josh.mccreary@nhccare.com. Whether or not you plan to attend the Meeting, we urge you to vote and submit your proxy in advance of the Meeting by one of the methods described in the proxy materials for the Meeting. At the 2024 Meeting of the Shareholders, we will vote on the following items and any other matters that are properly presented: 1) The re-election of J. Paul Abernathy, M.D. and Robert G. Adams as directors to each hold office for a three (3) year term and until their successors have been duly elected and qualified; 2) To consider an advisory vote on compensation of our Named Executive Officers; and 3) Transact such other business as may properly come before the Meeting or any continuances of it. The Board has chosen the close of business on Tuesday, March 12, 2024, as the record date for the determination of shareholders who must be notified of and who are eligible to vote at the Meeting or at any postponement or adjournment thereof. It is NHC's desire to conduct a safe and informative Meeting. In that interest, and in the interest of conducting a fair and orderly Meeting, NHC intends to observe its rules of conduct. A copy of the rules of conduct will be made available on the NHC website (www.nhccare.com) and at the Meeting. Any deliberate violation of these rules of conduct or an attempt to disrupt the Meeting will be considered cause for expulsion from the Meeting or the question-and-answer session. The Chairman will exercise his judgment on any procedural matters not addressed in these rules of conduct. Thank you for your cooperation and for joining NHC at the Meeting. Please use the toll-fre

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing